Chaudhari Shivraj Singh, CMD, Central Mine Planning & Design Institute (CMPDI) said the company will maintain a steady revenue mix while gradually scaling non-coal opportunities.…
Motilal Oswal Financial Services reiterated its ‘buy’ rating on Laurus Labs Ltd, predicting over 30% upside with a target price of ₹1,280, expecting 16% earnings…
Steel stocks rallied as brokerages flagged improving spreads, firm domestic demand and supportive global cues, with Macquarie and HSBC turning constructive on ferrous players including…
Vodafone Idea’s subscriber losses in January marks a significant improvement from the sustained monthly losses of about 1–2 million subscribers seen through most of 2024…
Gold and silver rose in Friday’s futures trade. April gold increased ₹1,914 to ₹1.46 lakh per 10g on MCX, and May silver jumped ₹8,540 to…
Natco Pharma also plans to launch a pen device version in April 2026, priced between ₹4,000 and ₹4,500 per month, depending on dosage.
Claudio Galimberti, Chief Economist & Global Director of Market Analysis at Rystad Energy says supply bottlenecks and slow production recovery could keep energy markets volatile…
The fall in copper price was expected, not the timing and pace. Despite its vital role in the world’s digital transition, near-term prices may remain…
Discounts on physical gold in India narrowed due to festival buying and global price corrections. Rajesh Rokde noted a 10% sales increase during Gudi Padwa.
Citi upgraded Dr Lal Pathlabs Ltd to ‘buy’ from ‘sell’, targeting ₹1,650 per share. The diagnostics sector has stabilized, with expected 10-12% organic revenue growth…